O'Shaughnessy Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.4M	Buy	125,662 +17,673	+16%	+$594K	0.02%	654
2025 Q4	$4.63M	Buy	107,989 +95,605	+772%	+$3.6M	0.03%	536
2025 Q3	$351K	Buy	+12,384	New	+$370K	﹤0.01%	1670
2022 Q2	–	Sell	-1,038	Closed	-$31K	–	1339
2022 Q1	$31K	Hold	1,038	–	–	﹤0.01%	1196
2021 Q4	$27K	Hold	1,038	–	–	﹤0.01%	1201
2021 Q3	$38K	Buy	+1,038	New	+$40.9K	﹤0.01%	1758

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

O'Shaughnessy Asset Management's RIGL Position: Q1 2026 in Review

O'Shaughnessy Asset Management increased its Rigel Pharmaceuticals (RIGL) stake by 16% in Q1 2026, buying an estimated $594K and bringing the position to 125,662 shares worth $3.4M. The position accounts for 0.02% of the portfolio, ranked #654.

O'Shaughnessy Asset Management first reported a position in RIGL in Q3 2021 and has held it in 6 quarters since. The position peaked at $4.63M in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

O'Shaughnessy Asset Management held 125,662 shares of Rigel Pharmaceuticals worth $3.4M as of Q1 2026.
O'Shaughnessy Asset Management bought 17,673 Rigel Pharmaceuticals shares in Q1 2026, an estimated $594K.
Rigel Pharmaceuticals made up 0.02% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #654 holding.
O'Shaughnessy Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
O'Shaughnessy Asset Management's Rigel Pharmaceuticals position peaked at $4.63M in Q4 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.